GlassScriptPhysician profile
Roy M C Harris
NPI 1780692533
$18,818.07
in general payments reported to CMS, 2019-2025
68 companies · $2,832 in 2025
The $2,832 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,495 · 2020: $2,178 · 2021: $2,420 · 2022: $2,695 · 2023: $3,387 · 2024: $2,811 · 2025: $2,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,029.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,611.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,955.42 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,899.24 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $1,295.03 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,217.93 | 2019-2025 | Jardiance, Spiriva Respimat |
| Lilly USA, LLC | $1,082.39 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $997.23 | 2019-2025 | |
| Amgen INC. | $853.20 | 2019-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $647.87 | 2021-2024 | |
| Astellas Pharma US INC | $505.24 | 2019-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $377.56 | 2019-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $361.38 | 2019-2025 | Gardasil 9, Gardasil, Capvaxive |
| Allergan, INC. | $343.69 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $320.26 | 2019-2023 | Trintellix |
| Merz North America, INC. | $311.79 | 2019-2025 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $296.34 | 2019-2023 | Seglentis, Livalo |
| Abbott Laboratories | $241.61 | 2021-2025 | Freestyle Libre 3, Id Now Instrument, Freestyle Libre 2 |
| Amarin Pharma, INC. | $236.30 | 2019-2022 | |
| Boston Scientific Corporation | $195.82 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Biohaven Pharmaceutical Holding Company LTD. | $193.05 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $188.15 | 2021 | |
| Exact Sciences Corporation | $183.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $154.27 | 2019-2024 | Spravato |
| Phathom Pharmaceuticals, INC. | $145.08 | 2024-2025 | Voquezna |
| Horizon Therapeutics Plc | $136.30 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $134.82 | 2019-2025 | |
| Neos Therapeutics, LP | $133.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $109.71 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $104.87 | 2020-2023 | Eliquis |
| Hologic Sales and Service, LLC | $101.31 | 2019-2024 | Aptima |
| Bausch Health US, LLC | $99.30 | 2020-2021 | |
| Antares Pharma, INC. | $87.34 | 2020-2024 | Xyosted |
| Alnylam Pharmaceuticals INC. | $79.70 | 2025 | Amvuttra |
| Esperion Therapeutics, INC. | $70.39 | 2020-2021 | |
| Sanofi Pasteur INC. | $67.18 | 2019-2023 | |
| Pacira Therapeutics, INC. | $66.13 | 2019 | |
| Ibsa Pharma INC. | $58.65 | 2021-2022 | |
| Seqirus USA INC | $58.30 | 2022-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Qiagen, LLC | $53.12 | 2021-2023 | Quantiferon-Tb Gold Plus |
| Fidia Pharma USA INC. | $52.68 | 2019-2024 | Hymovis |
| Dexcom, INC. | $52.14 | 2023-2024 | Dexcom G6 Transmitter |
| Eisai INC. | $51.62 | 2020-2021 | |
| Daiichi Sankyo INC. | $50.76 | 2025 | Injectafer |
| Cranial Technologies, INC | $47.32 | 2023-2025 | Doc Band |
| Medtronic, INC. | $44.21 | 2022 | |
| Verity Pharmaceuticals INC. | $44.14 | 2025 | Tlando |
| Alexion Pharmaceuticals, INC. | $43.19 | 2023 | Strensiq |
| Collegium Pharmaceutical, INC. | $37.23 | 2023-2024 | Xtampza |
| Bioventus LLC | $36.57 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $36.40 | 2019-2021 | |
| Corium, LLC | $33.88 | 2022 | |
| Revance Therapeutics, INC. | $32.86 | 2025 | Daxxify |
| Idorsia Pharmaceuticals US INC | $29.61 | 2023 | Quviviq |
| Aimmune Therapeutics, INC. | $28.65 | 2025 | Zenpep |
| Ironwood Pharmaceuticals, INC | $18.80 | 2023 | Linzess |
| Therapeuticsmd, INC. | $18.01 | 2020 | |
| Azurity Pharmaceuticals, INC. | $17.10 | 2025 | Azmiro |
| Intra-Sana Laboratories | $16.86 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Halozyme INC | $16.86 | 2023 | |
| Xeris Pharmaceuticals, INC. | $16.80 | 2024 | Gvoke Hypopen |
| Currax Pharmaceuticals LLC | $16.41 | 2025 | Contrave |
| Amag Pharmaceuticals, INC. | $16.29 | 2019 | |
| Kaleo, INC. | $16.13 | 2022 | |
| Silk Road Medical, INC. | $16.07 | 2019 | |
| Becton, Dickinson and Company | $15.83 | 2021 | |
| Stryker Corporation | $14.89 | 2024 | Augment Injectable |
| Otsuka America Pharmaceutical, INC. | $13.79 | 2021 | |
| Ethicon US, LLC | $7.92 | 2020 |
Drugs and devices associated with these payments
Qulipta $708Ozempic $604Airsupra $522Shingrix $520Nurtec Odt $517Ubrelvy $516Jardiance $512Arexvy $498Rybelsus $493Breztri $434Trelegy Ellipta $391Farxiga $389Fasenra $356Kerendia $352Veozah $337Mounjaro $315Evenity $306Linzess $294Creon $245Zavzpret $228Wegovy $217Vraylar $199Prolia $194Zepbound $187Prevnar 20 $152Spiriva Respimat $149Comirnaty $146Voquezna $145Cologuard Collection Kit $136General - Pain Management $113Bexsero $110Abrysvo $110Xifaxan $109Repatha $101Spravato $100Amvuttra $79.70Paxlovid $76.01Freestyle Libre 3 $73.69Gardasil 9 $64.19Dexcom G6 Transmitter $52.14Viberzi $51.29Injectafer $50.76Gardasil $50.67The Cologuard Plus Collection Kit $47.88Doc Band $47.32Aptima $46.03Capvaxive $44.32Tlando $44.14Otezla $40.12Myrbetriq $38.79Id Now Instrument $37.40Xtampza $37.23Freestyle Libre 2 $36.53Xyosted $36.14Daxxify $32.86Quviviq $29.61Quantiferon-Tb Gold Plus $29.43Zenpep $28.65Leqvio $27.67Entresto $27.67Livalo $27.40Seglentis $27.40Fluzone High-Dose $24.57Fluzone Quadrivalent Northern Hemisphere $24.57Flublok Quadrivalent Northern Hemisphere $24.57Fluad $23.90Flucelvax $23.90Xeomin $23.42Strensiq $23.41Trumenba $21.84Penbraya $21.84Synvisc-One $21.08Botox $21.02Wavewriter Alpha Prime 16 $20.02Vaxneuvance $19.87Trulicity $17.40Azmiro $17.10Hymovis $16.87Reltone 200 Mg $16.86Reltone 400 Mg $16.86Glycate $16.86Gvoke Hypopen $16.80Flucelvax Quadrivalent $16.77Fluad Quadrivalent $16.77Emgality $16.68Contrave $16.41Trintellix $15.15Augment Injectable $14.89Tzield $13.98Eliquis $13.69Vyndamax $11.24
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.